Skip to content

Observation on the Clinical Efficacy of Combined Use of Hé Mài Tiáo Shén Acupuncture and Nicardipine in the Treatment of Hypertensive Emergencies.

Observation on the Clinical Efficacy of Combined Use of Hé Mài Tiáo Shén Acupuncture and Nicardipine in the Treatment of Hypertensive Emergencies.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025002183
Enrollment
Unknown
Registered
2025-11-17
Start date
2025-11-30
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertensive emergencies

Interventions

Experimental Group:Acupuncture + Nicardipine intravenous infusion pump
Control Group:Nicardipine intravenous infusion

Sponsors

Affiliated Hospital of Nanjing University of Traditional Chinese Medicine (Jiangsu Provincial TCM Hospital)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Patients who meet the diagnostic criteria for hypertensive emergencies and the TCM diagnostic criteria for Liver Yang Rising syndrome. 2. Patients aged between 18 and 65 years, with no restriction on gender. 3. Patients with an acute onset of illness. 4. Patients who have provided informed consent and are willing to participate as subjects. The process of obtaining informed consent should comply with GCP regulations.

Exclusion criteria

Exclusion criteria: 1. Those with severe hepatic and renal functional impairment and immunodeficiency; 2. Those with cardiogenic shock, severe arrhythmia, sick sinus syndrome, and second to third-degree atrioventricular block, etc., severe heart disease; 3. Those who have experienced cerebrocardiovascular accidents, severe trauma, or major surgery within the past three months; 4. Those with secondary hypertension, a history of kidney disease, malignant tumors, bronchial asthma, and severe chronic diseases such as diabetes; 5. Those with infection or ulceration at the acupuncture site or the tip of the ear; 6. Pregnant and lactating women; 7. Those with incomplete clinical data.

Design outcomes

Primary

MeasureTime frame
blood pressure;Total Nicardipine dose;

Secondary

MeasureTime frame
Heart rate;Clinical Symptoms;High-sensitivity troponin I;N-terminal pro-B-type natriuretic peptide;

Countries

China

Contacts

Public ContactCao Wei Juan

Affiliated Hospital of Nanjing University of Traditional Chinese Medicine (Jiangsu Provincial Hospital of Traditional Chinese Medicine)

caoweijuan111@sina.com15861818890

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026